SLC5A2 and hypertensive disorder: Therefore, further investigations are needed to explore whether they can be considered for managing hypertension in patients with or without type 2 diabetes. Below is a discussion of published research articles that compare the analysis of different authors, which can give us greater insights into the efficacy of SGLT2 inhibitors in cardiovascular outcomes.